Hipertensão na doença renal crônica em tratamento conservador / Hypertension in chronic kidney disease under conservative treatment

A hipertensão arterial sistêmica (HAS) afeta aproximadamente 30% da população geral no mundo industrializado e é uma das principais causas de doença renal crônica (DRC), caracterizada por função renal anormal ou danos estruturais renais com mais de 3 meses de duração. A sua presença classifica o paciente hipertenso como de alto risco cardiovascular (CV). O controle pressórico é fundamental para diminuir a sua progressão e reduzir o risco de morbidade e mortalidade CV. A meta pressórica recomendada deve ser menor que 130x80mmHg para a maioria dos pacientes com DRC. O tratamento não medicamentoso tem como base as mesmas recomendações dos demais pacientes hipertensos. A terapia medicamentosa combinada deve ser iniciada o mais breve possível. Além dos inibidores do sistema renina angiotensina aldosterona, conhecidos por sua eficácia na DRC, os diuréticos e os bloqueadores de canal de cálcio compõem o trio de ouro utilizado no tratamento da HAS, capazes de reduzir o risco cardiovascular e desacelerar a progressão da doença renal. Em conclusão, a DRC é um preditor de risco CV e a presença concomitante de HAS aumenta expressivamente esse risco. A utilização da estratégia terapêutica adequada para manter os níveis pressóricos dentro das metas é fundamental na atenuação da progressão da doença renal e do risco

Systemic arterial hypertension (SAH) affects approximately 30% of the general population in the industrialized world and is a major cause of chronic kidney disease (CKD), characterized by abnormal renal function or structural damage lasting more than 3 months. Its presence classifies the hypertensive as a high cardiovascular (CV) risk patient. Blood pressure (BP) control is essential for slowing the progression and for reducing the risk of CV morbidity and mortality in patients with CKD. BP target <130x80mmHg is recommended for most hypertensives with CKD. Non pharmacological treatment is based on the same recommendations for other hypertensive patients. Combination drug therapy should be started as soon as possible. In addition to the renin angiotensin aldosterone system blockers, known for their effectiveness in CKD, diuretics and calcium channel blockers compose the gold trio used in the treatment of SAH, able to reduce cardiovascular risk and to slow the progression of kidney disease. In conclusion, CKD is a predictor of CV risk and the concomitant presence of SAH significantly increases this risk. The use of an appropriate therapeutic strategy to maintain BP control is crucial to mitigate the progression of kidney disease and CV

APOE and LDLR Gene Polymorphisms and Dyslipidemia Tracking. Rio de Janeiro Study.

BACKGROUND: Studies show an association between changes in apolipoprotein E (ApoE) and LDLR receptor with the occurrence of dyslipidemia. OBJECTIVES: To investigate the association between polymorphisms of the APOE (ε2, ε3, ε4) and LDLR (A370T) genes with the persistence of abnormal serum lipid levels in young individuals followed up for 17 years in the Rio de Janeiro Study. METHODS: The study included 56 individuals (35 males) who underwent three assessments at different ages: A1 (mean age 13.30 ± 1.53 years), A2 (22.09 ± 1.91 years) and A3 (31.23 ± 1.99 years). Clinical evaluation with measurement of blood pressure (BP) and body mass index (BMI) was conducted at all three assessments. Measurement of waist circumference (WC) and serum lipids, and analysis of genetic polymorphisms by PCR-RFLP were performed at A2 and A3. Based on dyslipidemia tracking, three groups were established: 0 (no abnormal lipid value at A2 and A3), 1 (up to one abnormal lipid value at A2 or A3) and 2 (one or more abnormal lipid values at A2 and A3). RESULTS: Compared with groups 0 and 1, group 2 presented higher mean values of BP, BMI, WC, LDL-c and TG (p < 0.01) and lower mean values of HDL-c (p = 0.001). Across the assessments, all individuals with APOE genotypes ε2/ε4 and ε4/ε4 maintained at least one abnormal lipid variable, whereas those with genotype ε2/ε3 did not show abnormal values (χ2 = 16.848, p = 0.032). For the LDLR genotypes, there was no significant difference among the groups. CONCLUSIONS: APOE gene polymorphisms were associated with dyslipidemia in young individuals followed up longitudinally from childhood.

APOE and LDLR Gene Polymorphisms and Dyslipidemia Tracking. Rio de Janeiro Study / Polimorfismos dos Genes APOE e RLDL e Tracking de Dislipidemia em Jovens. Estudo do Rio de Janeiro

Background: Studies show an association between changes in apolipoprotein E (ApoE) and LDLR receptor with the occurrence of dyslipidemia. Objectives: To investigate the association between polymorphisms of the APOE (ε2, ε3, ε4) and LDLR (A370T) genes with the persistence of abnormal serum lipid levels in young individuals followed up for 17 years in the Rio de Janeiro Study. Methods: The study included 56 individuals (35 males) who underwent three assessments at different ages: A1 (mean age 13.30 ± 1.53 years), A2 (22.09 ± 1.91 years) and A3 (31.23 ± 1.99 years). Clinical evaluation with measurement of blood pressure (BP) and body mass index (BMI) was conducted at all three assessments. Measurement of waist circumference (WC) and serum lipids, and analysis of genetic polymorphisms by PCR-RFLP were performed at A2 and A3. Based on dyslipidemia tracking, three groups were established: 0 (no abnormal lipid value at A2 and A3), 1 (up to one abnormal lipid value at A2 or A3) and 2 (one or more abnormal lipid values at A2 and A3). Results: Compared with groups 0 and 1, group 2 presented higher mean values of BP, BMI, WC, LDL-c and TG (p < 0.01) and lower mean values of HDL-c (p = 0.001). Across the assessments, all individuals with APOE genotypes ε2/ε4 and ε4/ε4 maintained at least one abnormal lipid variable, whereas those with genotype ε2/ε3 did not show abnormal values (χ2 = 16.848, p = 0.032). For the LDLR genotypes, there was no significant difference among the groups. Conclusions: APOE gene polymorphisms were associated with dyslipidemia in young individuals followed up longitudinally from childhood. .

Fundamento: Estudos demonstram a associação de alterações da apolipoproteína E (APOE) e do receptor da RLDL com a ocorrência de dislipidemia. Objetivos: Investigar a associação entre polimorfismos dos genes da APOE (APOE - ε2, ε3, ε4) e do receptor da LDL (RLDL - A370T) com a persistência de alterações dos níveis lipídicos séricos em jovens acompanhados há 17 anos no Estudo do Rio de Janeiro. Métodos: Foram estudados 56 indivíduos (35 masculinos) em três avaliações realizadas em idades distintas: A1 – média de idade: 13,30 ± 1,53 anos; A2 – média de idade: 22,09±1,91 anos e A3 – média de idade: 31,23±1,99 anos. Nas três avaliações foram determinados a pressão arterial (PA) e o índice de massa corporal (IMC). Em A2 e A3 foram obtidos a circunferência abdominal (CA) e os lípides séricos, e analisados os polimorfismos genéticos por PCR-RFLP. Com base no tracking de dislipidemia, três grupos foram constituídos: 0 (nenhum lípide alterado em A2 e A3), 1 (até um lípide alterado em A2 ou A3) e 2 (um ou mais lípides alterados em A2 e A3). Resultados: Em comparação aos grupos 0 e 1, o grupo 2 apresentou maiores médias de PA, IMC, CA, LDL-c e TG (p < 0,01) e menor média de HDL-c (p = 0,001) que os grupos 0 e 1. Todos os indivíduos com genótipo APOE ε2/ε4 e ε4/ε4 mantiveram durante as avaliações pelo menos um lípide alterado, enquanto que aqueles com genótipo ε2/ε3 não apresentaram alterações (χ2=16,848, p = 0,032). Para os genótipos RLDL não houve diferença significativa entre os grupos. Conclusões: O polimorfismo do gene APOE se associou à presença de dislipidemia em indivíduos jovens em acompanhamento longitudinal desde a infância. .

Pressao Arterial na Adolescencia, Adipocinas e Inflamacao no Adulto Jovem. Estudo do Rio de Janeiro / Blood Pressure in Adolescence, Adipokines and Inflammation in Young Adults. The Rio de Janeiro Study

Fundamento: O impacto pressão arterial (PA) na adolescência sobre outros fatores de risco cardiovascular em adultos jovens é importante para a prevenção primária. Objetivo: Avaliar a PA, índices antropométricos, perfil metabólico e inflamatório de jovens estratificados pelo comportamento da sua PA obtida há 18 anos. Métodos: Avaliaram-se 116 indivíduos, sendo 63 homes, pertencentes ao estudo do Rio de Janeiro (seguimento 17,76 ± 1,63 anos) em dois momentos: A1 (12,40 ± 1,49 anos) e A2 (30,09 ± 2,01 anos). Os 116 indivíduos foram divididos em dois grupos: GN (n = 71), PA normal em A1; e GH (n = 45): PA anormal em A1. A PA, o peso, a altura e o índice de massa corporal (IMC) foram obtidos em A1 e A2. Em A2, acrescentaram-se a circunferência abdominal (CA) e variáveis laboratoriais, metabólicas e inflamatórias. Resultados: 1) Os grupos não diferiram quanto à idade e sexo; 2) Em A2, GH apresentou maiores médias de peso, IMC, PA, insulina, HOMA-IR (p < 0,001), leptina (p < 0,02), Apolipoproteína B100 e A1 (p < 0,02), relação Apolipoproteína B100 / Apolipoproteína A1 (p < 0,010), maiores prevalências de sobrepeso/obesidade (p < 0,001), da CA aumentada (p < 0,001) e de hipertensão arterial (p < 0,02); 3) Não houve diferença entre os grupos para as variáveis inflamatórias; 4) Houve correlação positiva da PA em A1 com a PA, o IMC, e com a insulina, a leptina e o HOMA-IR em A2 (p < 0,05). Conclusões: A PA na adolescência se associou a maiores valores de PA, variáveis antropométricas e metabólicas na fase adulta jovem, mas não a variáveis inflamatórias. .

Background: The impact of blood pressure (BP) during adolescence on other cardiovascular risk factors in young adults is important for the primary prevention. Objective: To evaluate BP, anthropometric indexes, metabolic and inflammatory profiles in young individuals stratified by their BP behavior recorded for 18 years. Methods: A total of 116 individuals, of whom 63 were males, from the Rio de Janeiro study (follow-up of 17.76 ± 1.63 years), were assessed at two moments: A1 (12.40 ± 1.49 years) and A2 (30.09 ± 2.01 years). The 116 individuals were divided into two groups: GN (n = 71), of participants with normal BP at A1; and GH (n = 45), of those with abnormal BP at A1. BP, weight, height and body mass index (BMI) were measured at A1 and A2. At A2, abdominal circumference (AC) and laboratory, metabolic and inflammatory variables were included. Results: 1) No difference was observed between the groups as regards age and gender; 2) At A2, GH showed higher mean weight, BMI, BP, insulin, HOMA-IR (p < 0.001), leptin (p < 0.02), apolipoprotein B100 and A1 (p < 0.02), apolipoprotein B100 / apolipoprotein A1 ratio (p < 0.010); and higher prevalences of overweight/obesity (p < 0.001), of increased AC (p < 0.001) and of hypertension (p < 0.02); 3) No difference was observed between the groups as regards the inflammatory variables; 4) There was a positive correlation of BP at A1 with BP, BMI, insulin, leptin and HOMA-IR at A2 (p < 0.05). Conclusion: BP in adolescence was associated with higher values of BP, and anthropometric and metabolic variables in young adulthood, but not with inflammatory variables. .

Blood pressure in adolescence, adipokines and inflammation in young adults. The rio de janeiro study.

BACKGROUND: The impact of blood pressure (BP) during adolescence on other cardiovascular risk factors in young adults is important for the primary prevention. OBJECTIVE: To evaluate BP, anthropometric indexes, metabolic and inflammatory profiles in young individuals stratified by their BP behavior recorded for 18 years. METHODS: A total of 116 individuals, of whom 63 were males, from the Rio de Janeiro study (follow-up of 17.76 ± 1.63 years), were assessed at two moments: A1 (12.40 ± 1.49 years) and A2 (30.09 ± 2.01 years). The 116 individuals were divided into two groups: GN (n = 71), of participants with normal BP at A1; and GH (n = 45), of those with abnormal BP at A1. BP, weight, height and body mass index (BMI) were measured at A1 and A2. At A2, abdominal circumference (AC) and laboratory, metabolic and inflammatory variables were included. RESULTS: 1) No difference was observed between the groups as regards age and gender; 2) At A2, GH showed higher mean weight, BMI, BP, insulin, HOMA-IR (p < 0.001), leptin (p < 0.02), apolipoprotein B100 and A1 (p < 0.02), apolipoprotein B100 / apolipoprotein A1 ratio (p < 0.010); and higher prevalences of overweight/obesity (p < 0.001), of increased AC (p < 0.001) and of hypertension (p < 0.02); 3) No difference was observed between the groups as regards the inflammatory variables; 4) There was a positive correlation of BP at A1 with BP, BMI, insulin, leptin and HOMA-IR at A2 (p < 0.05). CONCLUSION: BP in adolescence was associated with higher values of BP, and anthropometric and metabolic variables in young adulthood, but not with inflammatory variables.

Desnervação simpática renal no tratamento da hipertensão arterial resistente : perspectivas atuais / Renal sympathetic denervation for resistant hypertension treatment : current perspectives

Os autores revisam o conceito de hipertensão arterial resistente e o envolvimento do sistema nervoso simpático na hipertensão arterial como base racional para a técnica de desnervação simpática renal (DSR), realizada por via percutânea. A presente revisão é resultado de uma busca ativa de artigos científicos com o nome "renal denervation" na base de dados Medline e PubMed. A técnica e os dispositivos empregados no procedimento são apresentados, bem como os resultados clínicos em seis, 12 e 24 meses após a intervenção com o cateter Symplicity. Observam-se reduções expressivas e progressivamente maiores da PAS e PAD após a DSR. A taxa de complicações foi mínima. Novos dispositivos para a DSR e respectivos estudos clínicos em andamento são citados. Em conclusão, a DSR apresenta-se como um procedimento efetivo e seguro para a abordagem da hipertensão arterial resistente. Resultados de estudos em andamento e tempo maior de seguimento desses pacientes são aguardados para confirmar os resultados iniciais e colocar em perspectiva a ampliação da utilização do procedimento na abordagem da hipertensão arterial.

The authors review the concept of resistant hypertension and the involvement of the sympathetic nervous system in hypertension as a rational basis for the technique of renal sympathetic denervation (RSD) performed percutaneously. This revision is the result of an active search for scientific articles with the term "renal denervation" in the Medline and PubMed databases. The techniques and devices used in the procedure are presented, as well as clinical outcomes at six, 12 and 24 months after the intervention with the Symplicity catheter. Significant decreases and progressively higher reductions of systolic and diastolic blood pressure were observed after RSD. The complication rate was minimal. New devices for RSD and its ongoing clinical studies are cited. In conclusion, the RSD presents itself as an effective and safe approach to resistant hypertension. Results from ongoing studies and longer follow-up of these patients are expected to confirm the initial results and put into perspective the expansion of the procedure use in hypertension approach.

Renal sympathetic denervation for resistant hypertension treatment : current perspectives.

The authors review the concept of resistant hypertension and the involvement of the sympathetic nervous system in hypertension as a rational basis for the technique of renal sympathetic denervation (RSD) performed percutaneously. This revision is the result of an active search for scientific articles with the term "renal denervation" in the Medline and PubMed databases. The techniques and devices used in the procedure are presented, as well as clinical outcomes at six, 12 and 24 months after the intervention with the Symplicity catheter. Significant decreases and progressively higher reductions of systolic and diastolic blood pressure were observed after RSD. The complication rate was minimal. New devices for RSD and its ongoing clinical studies are cited. In conclusion, the RSD presents itself as an effective and safe approach to resistant hypertension. Results from ongoing studies and longer follow-up of these patients are expected to confirm the initial results and put into perspective the expansion of the procedure use in hypertension approach.

Velocidade da onda de pulso, pressão arterial e adipocitocinas em adultos jovens: estudo do Rio de Janeiro / Pulse wave velocity, blood pressure and adipocytokines in young adults: the Rio de Janeiro study

FUNDAMENTO: Dados sobre a avaliação não invasiva vascular e suas relações com variáveis de risco cardiovascular são escassos em jovens. OBJETIVO: Avaliar a relação entre a velocidade de onda de pulso e a pressão arterial,variáveis antropométricas e metabólicas, incluindo as adipocitocinas, em indivíduos adultos jovens. MÉTODOS: Foram avaliados 96 indivíduos (51 homens) do estudo do Rio de Janeiro, de 26 a 35 anos (média 30,09 ± 1,92). Foram obtidos a velocidade de onda de pulso (método Complior), pressão arterial, índice de massa corporal, glicose, perfil lipídico, leptina, insulina, adiponectina e o índice de resistência à insulina HOMA-IR. Os indivíduos foram estratificados em três grupos segundo o tercil da VOP para cada sexo. RESULTADOS: O grupo com maior tercil de VOP mostrou maiores médias de pressão arterial sistólica, pressão arterial diastólica, pressão arterial média, índice de massa corporal, insulina, HOMA-IR e menores médias de adiponectina, além de maiores prevalências de diabetes mellitus/intolerância à glicose e hiperinsulinemia. Houve correlação significativa e positiva da velocidade da onda de pulso com pressão arterial sistólica, pressão arterial diastólica, pressão de pulso e pressão arterial média, índice de massa corporal, e LDL-colesterol e negativa com HDL-colesterol e adiponectina. Em modelo de regressão múltipla, após ajuste do HDL-colesterol, LDL-colesterol e adiponectina para sexo, idade, índice de massa corporal e pressão arterial média, apenas o sexo masculino e a pressão arterial média mantiveram correlação significativa com a velocidade de onda de pulso. CONCLUSÃO: A velocidade de onda de pulso em adultos jovens mostrou relação significativa com variáveis de risco cardiovascular, destacando-se o sexo masculino e a pressão arterial média como importantes variáveis no seu determinismo. Os achados sugerem que a medida da VOP pode ser útil para a identificação do acometimento vascular nessa faixa etária.

BACKGROUND: Data on noninvasive vascular assessment and their association with cardiovascular risk variables are scarce in young individuals. OBJECTIVE: To evaluate the association between pulse wave velocity and blood pressure, anthropometric and metabolic variables, including adipocytokines, in young adults. METHODS: A total of 96 individuals aged 26 to 35 years (mean 30.09 ± 1.92; 51 males) were assessed in the Rio de Janeiro study. Pulse wave velocity (Complior method), blood pressure, body mass index, glucose, lipid profile, leptin, insulin, adiponectin and insulin resistance index (HOMA-IR) were analyzed. Subjects were stratified into three groups according to the PWV tertile for each gender. RESULTS: The group with the highest pulse wave velocity (PWV) tertile showed higher mean systolic and diastolic blood pressure, mean blood pressure, body mass index, insulin, and HOMA-IR, as well as lower mean adiponectin; higher prevalence of diabetes mellitus/glucose intolerance and hyperinsulinemia. There was a significant positive correlation of PWV with systolic blood pressure, diastolic blood pressure, pulse pressure and mean blood pressure, body mass index, and LDL-cholesterol, and a negative correlation with HDL-cholesterol and adiponectin. In the multiple regression model, after adjustment of HDL-cholesterol, LDL-cholesterol and adiponectin for gender, age, body mass index and mean blood pressure, only the male gender and mean blood pressure remained significantly correlated with PWV. CONCLUSION: PWV in young adults showed a significant association with cardiovascular risk variables, especially in the male gender, and mean blood pressure as important determinant variables. The findings suggest that PWV measurement can be useful for the identification of vascular impairment in this age group.

Pulse wave velocity, blood pressure and adipocytokines in young adults: the Rio de Janeiro study.

BACKGROUND: Data on noninvasive vascular assessment and their association with cardiovascular risk variables are scarce in young individuals. OBJECTIVE: To evaluate the association between pulse wave velocity and blood pressure, anthropometric and metabolic variables, including adipocytokines, in young adults. METHODS: A total of 96 individuals aged 26 to 35 years (mean 30.09 ± 1.92; 51 males) were assessed in the Rio de Janeiro study. Pulse wave velocity (Complior method), blood pressure, body mass index, glucose, lipid profile, leptin, insulin, adiponectin and insulin resistance index (HOMA-IR) were analyzed. Subjects were stratified into three groups according to the PWV tertile for each gender. RESULTS: The group with the highest pulse wave velocity (PWV) tertile showed higher mean systolic and diastolic blood pressure, mean blood pressure, body mass index, insulin, and HOMA-IR, as well as lower mean adiponectin; higher prevalence of diabetes mellitus/glucose intolerance and hyperinsulinemia. There was a significant positive correlation of PWV with systolic blood pressure, diastolic blood pressure, pulse pressure and mean blood pressure, body mass index, and LDL-cholesterol, and a negative correlation with HDL-cholesterol and adiponectin. In the multiple regression model, after adjustment of HDL-cholesterol, LDL-cholesterol and adiponectin for gender, age, body mass index and mean blood pressure, only the male gender and mean blood pressure remained significantly correlated with PWV. CONCLUSION: PWV in young adults showed a significant association with cardiovascular risk variables, especially in the male gender, and mean blood pressure as important determinant variables. The findings suggest that PWV measurement can be useful for the identification of vascular impairment in this age group.

Síndrome metabólica: o risco cardiovascular é maior que o risco dos seus componentes isoladamente / Metabolic syndrome: is cardiovascular risk higher than for its individual components

A descrição de síndrome metabólica que, inicialmente, buscava um elo entre o diabetes e a doença cardiovascular,sofreu mudanças com o avanço do conhecimento. Várias questões se destacaram, dentre elas a discrepância entre os critérios diagnósticos que implicam diferentes prevalências da síndrome metabólica dependendo dadefinição considerada, e a exclusão de fatores de risco como o tabagismo e a LDL elevados. Outras dúvidaspertinentes são relativas à validade de se considerar o diabetes mellitus tipo 2 como parte da síndrome metabólica e quanto o seu tratamento deve ser diferente do tratamento de seus componentes isoladamente. Essaúltima dúvida é relevante, pois uma vez estabelecida como doença, medicações indicadas para o tratamentoespecífico da síndrome, e não apenas para os fatores de risco, podem ser desenvolvidas. Por essa razão, e emvirtude das muitas e diferentes definições existentes, há uma confusão considerável e ausência decomparabilidade entre os estudos. Assim, apesar de extensas investigações, ainda não há um padrão-ouro para a definição de síndrome metabólica, que continua na pauta dos debates. Nesta revisão, investigou-se seos componentes individuais da síndrome metabólica estão relacionados com o risco de doença cardiovascular,e em que medida isto ocorre.

A velocidade da onda de pulso em jovens: estudo do Rio de Janeiro / Pulse wave vocity in young adults: study of Rio de Janeiro / La velocidad de la onda de pulso en jóvenes: estudio de Rio de Janeiro

FUNDAMENTO: A velocidade da onda de pulso (VOP) pode ser marcador de comprometimento cardiovascular, porém existem poucos estudos em adultos jovens. OBJETIVO: Avaliar a associação da pressão arterial (PA), variáveis antropométricas e metabólicas, atuais e obtidas 13 anos antes, na infância e adolescência, com a VOP. MÉTODOS: Sessenta indivíduos foram acompanhados longitudinalmente e estratificados em dois grupos segundo o percentil da pressão arterial (PA) obtido 13 anos antes: Grupo 1 (G1): percentil da PA < 50 (n = 25, 11M, 26,4 anos) e Grupo 2 (G2): percentil da PA > 95 (n = 35, 19M, 25,4 anos). Foram submetidos a avaliação clínica, análise laboratorial e medidas da VOP pelo método Complior. RESULTADOS: G1 apresentou maior média de idade; G2 exibiu maior média de: peso, PA sistólica (PAS), PA diastólica (PAD), PA média (PAM), VOP e glicemia, e menor média de HDL-colesterol. PAS, PAM e frequência cardíaca (FC) obtidas na infância e adolescência apresentaram correlação significativa com a VOP. Peso, altura, cintura, relação cintura/quadril, PAS, PAD, pressão de pulso (PP), PAM e creatinina atuais apresentaram correlação positiva e significativa com a VOP. A comparação das médias de VOP ajustadas pela PAS, PAD, PAS e PAD, PAM e PP não mostrou diferença estatisticamente significativa entre os grupos. CONCLUSÃO: O percentil da PA na infância/adolescência mostrou-se relacionado à distensibilidade arterial, avaliada pela VOP, 13 anos após. Alterações da VOP podem ser identificadas em indivíduos jovens, sugerindo que o comprometimento vascular precoce pode estar presente nessa faixa etária, relacionado também a pressão arterial, variáveis antropométricas e metabólicas.

BACKGROUND: Pulse wave velocity (PWV) can be a marker of cardiovascular impairment, but there are few studies in young adults. OBJECTIVE: To evaluate the association between blood pressure (BP), current anthropometric and metabolic variables and those obtained 13 years earlier, in childhood and adolescence, with PWV. METHODS: Sixty individuals were followed longitudinally and split into two groups according to the percentile of blood pressure (BP) obtained 13 years earlier: Group 1 (G1): BP percentile < 50 (n = 25, 11M, 26.4 years old) and Group 2 (G2): BP > 95 percentile (n = 35, 19M, 25.4 years old). The individuals underwent clinical evaluation, laboratory analysis and measurements of PWV through the Complior method. RESULTS: G1 showed higher mean age; G2 showed greater mean weight, systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), PWV and blood glucose, and lower mean HDL-cholesterol. SBP, MAP and heart rate (HR) obtained during childhood and adolescence significantly correlated with PWV. Current weight, height, waist-hip ratio, SBP, DBP, pulse pressure (PP), MAP and creatinine presented a positive and significant correlation with PWV. A comparison of the average PWV adjusted for SBP, DBP, SBP and DBP, MAP and PP showed no statistically significant difference between groups. CONCLUSION: The percentile of BP in childhood/adolescence related to arterial distensibility assessed by PWV 13 years later. Changes in PWV can be identified in young individuals suggesting that early vascular impairment may be present in this age group, also related to blood pressure, anthropometric and metabolic variables.

FUNDAMENTO: La velocidad de la onda de pulso (VOP), puede ser un marcador de compromiso cardiovascular, aunque existen pocos estudios en adultos jóvenes. OBJETIVO: Evaluar la asociación de la presión arterial (PA), variables antropométricas y metabólicas actuales y también obtenidas 13 años antes, en la infancia y en la adolescencia, con la VOP. MÉTODOS: Sesenta individuos fueron seguidos longitudinalmente y estratificados en dos grupos según el percentil de la presión arterial (PA) obtenido 13 años antes: Grupo 1(G1): percentil de la PA < 50 (n = 25, 11M, 26,4 años) y Grupo 2 (G2): percentil de la PA > 95 (n = 35, 19M, 25,4 años). Fueron sometidos a evaluación clínica, análisis laboratorial y medidas de la VOP por el método Complior. RESULTADOS: G1 presentó un promedio mayor de edad; G2 mostró un promedio mayor de: peso, PA sistólica (PAS), PA diastólica (PAD), PA promedio (PAP), VOP y glucemia, y menor promedio de HDL-colesterol. La PAS, PAP y la frecuencia cardíaca (FC), obtenidas en la infancia y en la adolescencia presentaron una correlación significativa con la VOP. El peso, altura, cintura, relación cintura/cadera, PAS, PAD, la presión de pulso (PP), PAP y la creatinina actuales, presentaron una correlación positiva y significativa con la VOP. La comparación de los promedios de VOP ajustados por las PAS, PAD, PAS y PAD, PAP y PP no arrojó ninguna diferencia estadísticamente significativa entre los grupos. CONCLUSIÓN: El percentil de la PA en la infancia/adolescencia tuvo una relación con la distensibilidad arterial, evaluada por la VOP, 13 años después. Las alteraciones de la VOP pueden ser identificadas en individuos jóvenes, sugiriendo que el compromiso vascular en edad temprana, puede estar presente en esa franja etaria, relacionando también la presión arterial, las variables antropométricas y metabólicas.

Pulse wave velocity in young adults: study of Rio de Janeiro.

BACKGROUND: Pulse wave velocity (PWV) can be a marker of cardiovascular impairment, but there are few studies in young adults. OBJECTIVE: To evaluate the association between blood pressure (BP), current anthropometric and metabolic variables and those obtained 13 years earlier, in childhood and adolescence, with PWV. METHODS: Sixty individuals were followed longitudinally and split into two groups according to the percentile of blood pressure (BP) obtained 13 years earlier: Group 1 (G1): BP percentile < 50 (n = 25, 11M, 26.4 years old) and Group 2 (G2): BP > 95 percentile (n = 35, 19M, 25.4 years old). The individuals underwent clinical evaluation, laboratory analysis and measurements of PWV through the Complior method. RESULTS: G1 showed higher mean age; G2 showed greater mean weight, systolic blood pressure (SBP), diastolic blood pressure (DBP), mean arterial pressure (MAP), PWV and blood glucose, and lower mean HDL-cholesterol. SBP, MAP and heart rate (HR) obtained during childhood and adolescence significantly correlated with PWV. Current weight, height, waist-hip ratio, SBP, DBP, pulse pressure (PP), MAP and creatinine presented a positive and significant correlation with PWV. A comparison of the average PWV adjusted for SBP, DBP, SBP and DBP, MAP and PP showed no statistically significant difference between groups. CONCLUSION: The percentile of BP in childhood/adolescence related to arterial distensibility assessed by PWV 13 years later. Changes in PWV can be identified in young individuals suggesting that early vascular impairment may be present in this age group, also related to blood pressure, anthropometric and metabolic variables.

Associação entre ácido úrico e variáveis de risco cardiovascular em uma população não hospitalar / Association between uric acid and cardiovascular risk variables in a non-hospitalized population / Asociación entre ácido úrico y variables de riesgo cardiovascular en una población no hospitalaria

FUNDAMENTO: A associação entre ácido úrico (AU) e as variáveis de risco cardiovascular permanece controversa em estudos epidemiológicos. OBJETIVO: Avaliar a associação entre o AU, pressão arterial (PA), índices antropométricos e variáveis metabólicas em população não hospitalar estratificada por quintis de AU. MÉTODOS: Em estudo observacional transversal, foram avaliados 756 indivíduos (369M), com idade de 50,3 ± 16,12 anos, divididos em quintis de AU. Foram obtidos PA, índice de massa corporal (IMC), circunferência abdominal (CA), AU, glicose, insulina, HOMA-IR, colesterol (CT), LDL-c, HDL-c, triglicerídeos (TG), creatinina (C). Foi calculada a taxa de filtração glomerular estimada (TFGE) e considerada hipertensão arterial (HA) quando a PA > 140x90 mmHg, sobrepeso/obesidade (S/O) quando IMC > 25 kg/m² e síndrome metabólica (SM) de acordo com a I Diretriz Brasileira de SM. RESULTADOS: 1) Não houve diferença entre os grupos na distribuição por sexo e faixa etária; 2) Os maiores quintis de AU apresentaram maiores médias de idade (p < 0,01), IMC, CA (p < 0,01), PAS, PAD (p < 0,001), CT, LDL-c, TG (p < 0,01), C e TFGE (p < 0,001) e menor média de HDL-c (p < 0,001); 3) O grupo com maior quintil de AU mostrou maiores prevalências de HA, S/O e SM (p < 0,001); 4) Maiores percentuais dos menores quintis de insulina (p < 0,02) e de HOMA-IR (p < 0,01) foram encontrados nos menores quintis de AU; 5) Em análise de regressão logística, o AU e as variáveis que compõem a SM apresentaram-se associados à ocorrência de SM (p < 0,01). CONCLUSÃO: Maiores quintis de ácido úrico associaram-se a pior perfil de risco cardiovascular e a pior perfil de função renal na amostra populacional não hospitalar estudada.

BACKGROUND: The association between uric acid (UA) and cardiovascular risk variables remains a controversial issue in epidemiological studies. OBJECTIVE: To evaluate the association between UA, blood pressure (BP), anthropometric indices and metabolic variables in a non-hospitalized population stratified by UA quintiles. METHODS: A cross-sectional observational study evaluated 756 individuals (369 males), aged 50.3 ± 16.12 years, divided in UA quintiles. BP, body mass index (BMI), abdominal circumference (AC), UA, glucose, insulin, HOMA-IR, total cholesterol (TC), LDL-c, HDL-c, triglycerides (TG) and creatinine (C) levels were obtained. The estimated glomerular filtration rate (eGFR) was calculated and arterial hypertension (AH) was considered when BP > 140x90 mmHg, overweight/obesity (OW/O) was considered when BMI > 25 kg/m² and metabolic syndrome (MS) was established according to the I Brazilian Guideline of MS. RESULTS: 1) There was no difference between the groups regarding the distribution by sex and age range; 2) The highest UA quintiles presented higher mean age (p < 0.01), BMI, AC (p < 0.01), SBP, DBP (p < 0.001), TC, LDL-c, TG (p < 0.01), C and eGFR (p < 0.001) and lower mean HDL-c (p < 0.001); 3) The group with the highest UA quintile showed higher prevalence of AH, OW/O and MS (p < 0.001); 4) Higher percentages of the lowest quintiles of insulin (p < 0.02) and HOMA-IR (p < 0.01) were observed with the lowest quintiles of UA; 5) A logistic regression analysis showed that UA and the variables that compose MS were associated with the occurrence of MS (p < 0.01). CONCLUSION: Higher quintiles of uric acid were associated with a worse cardiovascular risk profile and a worse kidney function profile in the non-hospitalized population sample studied.

FUNDAMENTO: La asociación entre ácido úrico (AU) y las variables de riesgo cardiovascular permanece controvertida en estudios epidemiológicos. OBJETIVO: Evaluar la asociación entre el AU, presión arterial (PA), índices antropométricos y variables metabólicas en población no hospitalaria estratificada por quintiles de AU. MÉTODOS: En estudio observacional transversal, se evaluaron a 756 individuos (369 hombres), con promedio de edad de 50,3 ± 16,12 años, divididos en quintiles de AU. Se obtuvieron PA, índice de masa corporal (IMC), circunferencia abdominal (CA), dosis de AU, glucosa, insulina, HOMA-IR, colesterol (CT), LDL-c, HDL-c, triglicéridos (TG), creatinina (C). Se calculó la tasa de filtración glomerular estimada (TFGE) y considerada como hipertensión arterial (HA) cuando la PA > 140 x 90 mmHg, sobrepeso/obesidad (S/O) cuando IMC > 25 kg/m² y síndrome metabólico (SM) de acuerdo con la I Directriz Brasileña de SM. RESULTADOS: 1) no hubo diferencia entre los grupos en la distribución por sexo y grupo de edad; 2) los mayores quintiles de AU presentaron mayores promedios de edad (p < 0,01), IMC, CA (p < 0,01), PAS, PAD (p < 0,001), CT, LDL-c, TG (p < 0,01), C y TFGE (p < 0,001) y menor promedio de HDL-c (p < 0,001); 3) el grupo con mayor quintil de AU reveló mayores prevalencias de HA, S/O y SM (p < 0,001); 4) mayores porcentuales de los menores quintiles de insulina (p < 0,02) y de HOMA-IR (p < 0,01) fueron encontrados en los menores quintiles de AU; 5) en análisis de regresión logística, el AU y las variables que componen la SM se presentaron asociados a la ocurrencia de SM (p < 0,01). CONCLUSIÓN: Mayores quintiles de ácido úrico se asociaron a un peor perfil de riesgo cardiovascular y a un peor perfil de función renal en la muestra poblacional no hospitalaria estudiada.

Association between uric acid and cardiovascular risk variables in a non-hospitalized population.

BACKGROUND: The association between uric acid (UA) and cardiovascular risk variables remains a controversial issue in epidemiological studies. OBJECTIVE: To evaluate the association between UA, blood pressure (BP), anthropometric indices and metabolic variables in a non-hospitalized population stratified by UA quintiles. METHODS: A cross-sectional observational study evaluated 756 individuals (369 males), aged 50.3 ± 16.12 years, divided in UA quintiles. BP, body mass index (BMI), abdominal circumference (AC), UA, glucose, insulin, HOMA-IR, total cholesterol (TC), LDL-c, HDL-c, triglycerides (TG) and creatinine (C) levels were obtained. The estimated glomerular filtration rate (eGFR) was calculated and arterial hypertension (AH) was considered when BP > 140x90 mmHg, overweight/obesity (OW/O) was considered when BMI > 25 kg/m² and metabolic syndrome (MS) was established according to the I Brazilian Guideline of MS. RESULTS: 1) There was no difference between the groups regarding the distribution by sex and age range; 2) The highest UA quintiles presented higher mean age (p < 0.01), BMI, AC (p < 0.01), SBP, DBP (p < 0.001), TC, LDL-c, TG (p < 0.01), C and eGFR (p < 0.001) and lower mean HDL-c (p < 0.001); 3) The group with the highest UA quintile showed higher prevalence of AH, OW/O and MS (p < 0.001); 4) Higher percentages of the lowest quintiles of insulin (p < 0.02) and HOMA-IR (p < 0.01) were observed with the lowest quintiles of UA; 5) A logistic regression analysis showed that UA and the variables that compose MS were associated with the occurrence of MS (p < 0.01). CONCLUSION: Higher quintiles of uric acid were associated with a worse cardiovascular risk profile and a worse kidney function profile in the non-hospitalized population sample studied.

[Overweight and cardiovascular risk among young adults followed-up for 17 years: the Rio de Janeiro study, Brazil].

BACKGROUND: The adoption of primary prevention measures among young people has a favorable impact on the context of cardiovascular diseases. OBJECTIVE: To assess blood pressure (BP) and cardiovascular risk variables among young adults stratified according to the body mass index (BMI) behavior obtained along 17 years, since childhood/adolescence (C/A). METHODS: Three assessments were carried out in 115 individuals pertaining to the study cohort of Rio de Janeiro, Brazil. A1: 12.97 +/- 1.48 years old; A2: 21.90 +/- 1.71 years old; A3: 30.65 +/- 2.00 years olds and divided into three groups according to BMI in the three assessments: Group N (always normal BMI; n=46), Group L (varying BMI; n=49) and Group O/O (always increased BMI; n=20). In A1, A2 and A3, BP and BMI were obtained. In A2 and A3, glucose (G) and lipidic profile were dosed. Also in A2, insulin (INS) was dosed and HOMA-IR was calculated. In A3, the measurement of waist circumference (WC), abdomen/hip relation (AHR) and body fat percentage (%BF) were added. RESULTS: 1) Group O/O presented higher mean values of increased BP (p<0.0001) at the three assessments; 2) In A3, Group O/O showed higher mean values for WC, AHR and %BF and prevalence of increased WC and metabolic syndrome (MS) (p<0.0001); 3) higher mean values were observed for INS, HOMA-IR, LDL-c in A2, and G, cholesterol, LDL-c and triglycerides in A3 for Group O/O (p<0.05); 4) masculine sex and O/O at A1 determined higher risk for MS occurrence in adult age. CONCLUSION: The presence of O/O since C/A was associated with higher BP values, anthropometric indexes and higher prevalence of MS in the young adult phase.